Table 2.
Preoperative and postoperative outcomes.
| Parameter | Value Preop | StdDev | min | MAX | Value Postop | StdDev | min | MAX |
|---|---|---|---|---|---|---|---|---|
| Number of treatments | 221 eyes / 114 patients | |||||||
| Female:Male | 123:98 | |||||||
| OD:OS | 111:110 | |||||||
| Age (years) | 28 | 6 | 19 | 54 | ||||
| MRSEq (D) | -6.26 | 2.17 | -11.88 | -2.5 | +0.48 | 0.31 | -0.75 | 1.25 |
| M. Astigmatism (D) | 0.92 | 0.68 | 0 | 3.5 | 0.13 | 0.18 | 0 | 0.5 |
| CDVA (Snellen) | 20/20 | 2 | 20/40 | 20/20 | 20/21 | 2 | 20/32 | 20/20 |
| UDVA (Snellen) | — | — | — | — | 20/21 | 2 | 20/32 | 20/20 |
| K-readings (D) | 44.0 | 1.4 | 40.8 | 47.4 | 39.0 | 1.9 | 33.2 | 43.1 |
| Central corneal thickness (µm) | 527 | 24 | 477 | 582 | 445 | 32 | 361 | 520 |
| Central epithelial thickness (µm) | 52 | 2 | 47 | 62 | 55 | 2 | 47 | 67 |
| Central stromal thickness (µm) | 476 | 24 | 423 | 531 | 390 | 32 | 306 | 468 |